ArticleBlood cancer journal2020

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis.

Rahma Warsame et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.